Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

RXi Pharmaceuticals Corp Company Profile (NASDAQ:RXII)

Consensus Ratings for RXi Pharmaceuticals Corp (NASDAQ:RXII) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.67 (324.84% upside)

Analysts' Ratings History for RXi Pharmaceuticals Corp (NASDAQ:RXII)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/2/2014LaidlawInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
5/5/2014WainwrightInitiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
5/5/2014HC WainwrightInitiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/22/2012 forward)
Discuss RXi Pharmaceuticals Corp